Pre-treatment predictors of cardiac dose exposure in left-sided breast cancer radiotherapy patients after breast conserving surgery
نویسندگان
چکیده
Abstract Objectives This study aimed to identify high-risk factors for high cardiac radiation exposure, based on anatomical measurements taken from planning CT images of patients with left-sided breast cancer who underwent breast-conserving surgery and received radiotherapy. Methods We retrospectively analyzed 45 whole-breast radiotherapy, either under free breathing (27/45) or deep inspiratory breath-holding (DIBH) (18/45), after surgery. Six parameters were measured images, including treatment target volume (PTV), cardiopulmonary ratio (CVR), maximum margin distance, the relative distance between inferior boundaries heart PTV (DBIB(H2P)), axial contact para-sagittal (CCDps). Multiple linear regression analysis was performed using SPSS software explore correlation six parameters, body mass index (BMI), mean dose (MHD). Receiver operating characteristic (ROC) evaluate predictive power selected predictor exposure. Results Significant correlations observed MHD CVR, DBIB(H2P), CCDps parameters. Among them, CVR most important an area curve 0.915 a cut-off value 0.17. Conclusions The results indicated that are primary associated risk being significant predictor. Further prospective studies required determine whether these can be used would benefit DIBH technique.
منابع مشابه
cardiac damage in left breast cancer patients
Introduction :Today there is general awareness of the potential damage to the heart in left- sided (more than in rightsided) breast cancer radiotherapy. Material & Method: Historical changes in tumor and heart doses are presented here along with the impact of different RT techniques and volumes. Results: Individual and pharm...
متن کاملImproving radiotherapy after breast-conserving surgery.
Drs. Mouw and Harris have reviewed data from randomized clinical trials (RCTs) and from selected institutional experiences with whole breast irradiation (WBI), usually delivered with tangent pair radiation therapy (RT) over 5 to 7 weeks, accelerated whole-breast irradiation (AWBI), usually delivered over 3 to 4 weeks, and accelerated partial-breast irradiation (APBI), usually delivered in a sin...
متن کاملUnintended cardiac irradiation during left-sided breast cancer radiotherapy.
OBJECTIVE Cardiac irradiation during left-sided breast radiotherapy may lead to deleterious cardiac side effects. Using image guided radiotherapy, it is possible to exclude the heart from treatment fields and monitor reproducibility of virtual simulation (VS) fields at treatment delivery using electronic portal imaging (EPI). Retrospectively, we evaluate the incidence of cardiac irradiation at ...
متن کاملComparison of “heart and lung volume absorbed dose” between electron and photon boost radiotherapy after breast conserving surgery
Background: Breast conserving surgery (BCS) followed by radiotherapy (RT) has been widely accepted as the standard treatment in early stages of invasive breast cancer. The standard technique of RT includes whole breast irradiation (WBI). Additional tumor bed boost irradiation has also an important role in the local tumor control. But there are various controversial delivery methods. The aim of ...
متن کاملDosimetric comparison of treatment of left breast cancer using two different dose schedules Dosimetric comparison of treatment of left breast cancer using two different dose schedules
Background: To date, different kinds of treatment methods have been proposed for radiotherapy of cancer patients. Choosing the kind of treatment method affects the quality of the patient's treatment. This study aims to investigate the effect of the number of radiation treatment sessions on the dose received by the patient and the distribution of tumor dose and dose received by organs at risk in...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Oncologie
سال: 2023
ISSN: ['1765-2839', '1292-3818']
DOI: https://doi.org/10.1515/oncologie-2023-0134